Studies how food allergy and related conditions develop and run in families
Follows people with food allergy and related conditions, plus their relatives, over time.
Key facts
- Who runs it
- National Institute of Allergy and Infectious Diseases (NIAID)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Natural History and Genetics of Food Allergy and Related Conditions
- Status
- Recruiting
- People taking part
- 1,800 people, planned
- Started
- 29 Jul 2015
- Expected to end
- 15 Jun 2027
- Type of study
- Observational, 4 groups
- Record updated
- 10 November 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with food allergy or a related condition, their relatives, and healthy volunteers, to learn more about the causes and effects of food allergy.
- Age
- 2 to 99 years for visits at the NIH Clinical Center; from newborn to 99 years for mail-in samples or telehealth visits. Leukapheresis: 18 years or older.
- Sex
- All sexes can join.
- Disease stage
- People with a food allergy reaction and positive allergy tests, positive tests without symptoms, a suspected genetic disorder linked to food allergy, eosinophilic esophagitis (or suspected), or a history of atopic dermatitis. Relatives and healthy volunteers must not have the condition.
- Biomarker or test result
- Positive allergy skin prick test or allergen-specific IgE blood test for food allergen(s). For leukapheresis: white blood cell count above 2,500/microL, hemoglobin above 10 g/dL, platelets above 75,000/microL.
Main reasons for not taking part
- A condition that puts the person at undue risk or makes taking part unsuitable, as judged by the investigator or referring doctor
- Not able to take part for the whole study
- Taking part would not be expected to advance the study goals
- Relatives and healthy volunteers having endoscopy with biopsies: pregnant or breastfeeding, positive HIV, hepatitis B or C tests, or steroid use in the past 4 months
- Relatives and healthy volunteers having endoscopy with biopsies: under 18 years old, or history of eosinophilic esophagitis
The registry criteria, word for word
Show all 35 criteriaShow less
Other criteria
- GENERAL INCLUSION CRITERIA:; All participants must meet the following criteria:
- Be 2 to 99 years-old at the time of enrollment for participants who will be seen at the NIH CC; be 0 (newborn) to 99 years-old at the time of enrollment for participants who will submit mail-in samples or participate in telehealth visits. Only viable neonates will be enrolled
- Willing to allow storage of blood, buccal swabs, saliva, nasal swabs, stool samples, and other clinically appropriate tissue specimens for future use in medical research
- Required to have a primary care or other physician who will manage all health conditions related or unrelated to the study objectives; ADDITIONAL INCLUSION CRITERIA FOR AFFECTED PARTICIPANTS; In addition to the general criteria listed above, affected participants must meet 1 of the following criteria:
- Have a clinical history of an immediate hypersensitivity reaction to food(s) and be sensitized to food allergen(s) (as evidenced by positive SPT or allergen-specific IgE testing)
- Be sensitized (as evidenced by positive SPT or allergen-specific IgE testing) to food allergen(s) but have no overt clinical history of IgE-mediated symptoms when they eat that food(s)
- Have a suspected genetic or congenital disorder potentially associated with food allergy or related condition, as determined by the principal investigator (PI) or associate investigators (AIs)
- Have a diagnosis of eosinophilic esophagitis (EoE), or clinical suspicion for EoE as determined by the principal investigator (PI) or associate investigators (AIs)
- Have a history of atopic dermatitis based on self-report or physician assessment; ADDITIONAL INCLUSION CRITERIA FOR UNAFFECTED RELATIVES:; In addition to the general criteria listed above, unaffected relatives must meet the following criteria:
- Be a relative of an affected participant
- Be unaffected by food allergy (as determined by clinical history and/or allergy testing) or be unaffected by the genetic condition under study; ADDITIONAL INCLUSION CRITERIA FOR HEALTHY VOLUNTEERS; In addition to the general criteria listed above, healthy volunteers must meet the following criteria:
- Be unrelated to an affected participant
- Be unaffected by food allergy (as determined by clinical history and/or allergy testing) or be unaffected by the genetic condition under study; ADDITIONAL PROCEDURE- SPECIFIC INCLUSION CRITERIA:; The following additional inclusion criteria apply for participants undergoing leukapheresis:
- Age >= 18 years
- Stable hematologic parameters (definition: white blood cell count > 2,500/microL, hemoglobin > 10 g/dL, and platelet count > 75,000/microL); GENERAL EXCLUSION CRITERIA:; Participants will be excluded for any of the following:
- Presence of conditions that, in the judgment of the investigator or the referring physician, may put the participant at undue risk or make them unsuitable for participation in the study
- Inability to participate for the duration of the study
- The PI deems that participation in the study would not be expected to advance the study goals; ADDITIONAL PROCEDURE- SPECIFIC EXCLUSION CRITERIA; Additional exclusion criteria apply for unaffected relatives and healthy volunteers who are undergoing endoscopy with biopsies for research purposes. Unaffected relatives and healthy volunteers will be excluded from participating in this procedure if they meet any of the following criteria:
- uncontrolled asthma or Grade 3 or higher by the American Society of Anesthesiologist s Physical Status Classification System (https://journals.lww.com/anesthesiologyopen/fulltext/2026/04000/american_society_of_anesthesiologists_statement_on.2.aspx)
- history of adverse reaction to conscious sedation or general anesthesia required for endoscopy
- hemoglobin < 11 g/dL
- platelet count < 100,000 microL
- PT INR >1.3 or PTT prolonged by > 3 seconds
- pregnant or breastfeeding
- viral screens positive for HIV or hepatitis B or C
- severe unstable myocardial ischemia or cardiomyopathy
- severe hypoxemia due to chronic pulmonary disease
- recent abdominal surgery
- anticoagulant therapy that cannot be interrupted
- history of reflux disease within the last 3 years or use of acid-suppression medication (including over-the-counter medications such as Tums, Rolaids, Zantac, Prilosec OTC, or Prevacid OTC) within the last 2 months
- chronic GI or immunologic disease
- clinically indicated EGD or colonoscopy within the past 12 months
- use of systemic or inhaled corticosteroids within the past 4 months
- have a history of EGID including EoE
- younger than 18 years of age
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: NIH Clinical Center Office of Patient Recruitment (OPR)Taking people
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
- About 15 million Americans have a food allergy. Because there are no cures or effective prevention or treatment for food allergies, researchers want to learn more about them.
Objective:
- To learn more about the causes and effects of food allergy and related conditions.
Eligibility:
* People ages 2 99 who have food allergy and/or a related genetic or other condition * Their relatives * Healthy relatives and volunteers
Design:
* Participants will have at least 3 visits over 1 2 years, and then once a year for up to 12 years. Each may last a day or longer. * Participants will be screened with medical history, physical exam, and questionnaires. * Participants may have the following: * Blood tests * Allergy skin prick tests: Drops of allergens are placed on the back or arm. The skin is scratched under each drop. * Leukapheresis: blood is taken from a needle in one arm, passed through a machine, and returned through a needle in the other arm. * X-rays * Esophageal string test: One end of a string is taped to the cheek and the other end is packed into a capsule. When the capsule is swallowed, the string unwinds; it is left in for at least 1 hour. * EGD and colonoscopy: Biopsies are taken from the gastrointestinal system. * Tiny biopsies of skin * Photographs of the body * Collection of cells through: * Swab of nose, inside of cheek, or skin * Gentle skin scrape * Tape stripping: piece of tape is put on the skin and pulled off.
The 4 groups in the trial
- Affected Genetic
Have a suspected genetic or congenital disorder potentially associated with food allergy or related condition, as determined by the principal investigator (PI) or associate investigators (AIs).
- Affected Non-Syndromic Food
Individuals with a clinical history of immediate hypersensitivity reaction to foods and sensitized to food allergen(s) as evidenced by SPT or allergen-specific IgE testing.
- Allergic GI Disease
Individuals with a diagnosis or clinical suspicion of eosinophilic esophagitis (EoE), as determined by the principal investigator (PI) or associate investigators (AIs).
- Unaffected Relative / Healthy Volunteer
Unaffected relatives are relatives of affected; unaffected by food allergy or the genetic condition under study. Healthy volunteers are not related to affected and serve as controls.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorSaves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Natural History and Genetics of Food Allergy and Related Conditions
- Plain-language title
- Studies how food allergy and related conditions develop and run in familiesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 10 November 2026